Sumitomo Mitsui Trust Group
CDNA icon

Sumitomo Mitsui Trust Group’s CareDx CDNA Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34M Sell
1,191,630
-283,496
-19% -$6.17M 0.02% 544
2026
Q1 		$25.6M Buy
1,475,126
+28,510
+2% +$540K 0.02% 588
2025
Q4 		$27.3M Sell
1,446,616
-293,448
-17% -$4.92M 0.02% 594
2025
Q3 		$25.3M Buy
1,740,064
+503,136
+41% +$7.17M 0.01% 617
2025
Q2 		$24.2M Sell
1,236,928
-139,826
-10% -$2.48M 0.02% 616
2025
Q1 		$24.4M Sell
1,376,754
-121,264
-8% -$2.61M 0.02% 612
2024
Q4 		$32.1M Sell
1,498,018
-155,909
-9% -$3.79M 0.02% 567
2024
Q3 		$51.6M Sell
1,653,927
-922,334
-36% -$22.9M 0.04% 443
2024
Q2 		$40M Sell
2,576,261
-172,077
-6% -$2.08M 0.03% 486
2024
Q1 		$29.1M Sell
2,748,338
-126,561
-4% -$1.27M 0.02% 636
2023
Q4 		$34.5M Sell
2,874,899
-149,604
-5% -$1.23M 0.03% 586
2023
Q3 		$21.2M Buy
3,024,503
+87,378
+3% +$807K 0.02% 688
2023
Q2 		$25M Buy
2,937,125
+186,657
+7% +$1.56M 0.02% 661
2023
Q1 		$25.1M Buy
2,750,468
+187,308
+7% +$2.4M 0.02% 681
2022
Q4 		$29.2M Buy
2,563,160
+75,999
+3% +$1.13M 0.02% 638
2022
Q3 		$42.3M Buy
2,487,161
+314,136
+14% +$6.74M 0.03% 528
2022
Q2 		$46.7M Buy
2,173,025
+205,791
+10% +$5.71M 0.04% 531
2022
Q1 		$72.8M Buy
1,967,234
+465,319
+31% +$18.1M 0.05% 419
2021
Q4 		$68.3M Buy
1,501,915
+405,392
+37% +$21.2M 0.04% 453
2021
Q3 		$69.5M Sell
1,096,523
-80,478
-7% -$6.13M 0.04% 444
2021
Q2 		$108M Buy
1,177,001
+356,855
+44% +$28.4M 0.06% 336
2021
Q1 		$55.8M Buy
820,146
+35,363
+5% +$2.75M 0.03% 509
2020
Q4 		$56.9M Buy
784,783
+46,088
+6% +$2.67M 0.04% 486
2020
Q3 		$28M Buy
738,695
+23,845
+3% +$805K 0.02% 633
2020
Q2 		$25.3M Sell
714,850
-280,085
-28% -$7.97M 0.02% 645
2020
Q1 		$21.7M Buy
994,935
+385,926
+63% +$8.65M 0.02% 617
2019
Q4 		$13.1M Buy
609,009
+374,897
+160% +$8.6M 0.01% 715
2019
Q3 		$5.29M Buy
234,112
+221,009
+1,687% +$6.12M ﹤0.01% 780
2019
Q2 		$472K Buy
+13,103
New +$419K ﹤0.01% 939

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group's CDNA Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its CareDx (CDNA) stake by 19% in Q2 2026, selling an estimated $6.17M and leaving 1,191,630 shares worth $34M. The position accounts for 0.02% of the portfolio, ranked #544.

Sumitomo Mitsui Trust Group first reported a position in CDNA in Q2 2019 and has held it in 29 quarters since. The position peaked at $108M in Q2 2021. 228 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 1,191,630 shares of CareDx worth $34M as of Q2 2026.
  • Sumitomo Mitsui Trust Group sold 283,496 CareDx shares in Q2 2026, an estimated $6.17M.
  • CareDx made up 0.02% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #544 holding.
  • Sumitomo Mitsui Trust Group first reported a position in CareDx in Q2 2019 and has held it in 29 quarters since.
  • Sumitomo Mitsui Trust Group's CareDx position peaked at $108M in Q2 2021.
  • 228 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.